Korean J Med > Volume 92(5); 2017 > Article |
|
Author | Year | Patient No. | Tumor site | Technical success | Stent | Median stent patency (days) | Median survival (months) | Median No. of RFA sessions | Complications No. (%) |
---|---|---|---|---|---|---|---|---|---|
Steel et al. [10] | 2011 | 22 | Pancreatic cancer 16 | 21 (95.5) | Uncovered SEMS 21 | 114 | 2 | 4/21 (19) | |
CCa 6 | Cholecystitis 2 | ||||||||
Pancreatitis 1 | |||||||||
Rigor 1 | |||||||||
Tal et al. [12] | 2013 | 12 | Hilar CCa (B‐IV) 9 | 12 (100) | Plastic stent 12 | 6.4 | 1.5 | 6/12 (50%) | |
Others 3 | Hemobilia 3 (mortality: 2) | ||||||||
Figueroa‐Barojas et al. [6] | 2013 | 20 | CCa 11 | 20 (100) | Uncovered SEMS 1 | 5/20 (25%) | |||
Pancreatic cancer 7 | Partially/fully covered SEMS 13 | Pancreatitis 1 | |||||||
Other 2 | Cholecystitis 1 | ||||||||
Plastic stent 6 | Pain: 5 | ||||||||
Dolak et al. [5] | 2014 | 58 | Hilar CCa. 45 | 58 (100) | SEMSa 3 | 171 | 10.6 | 1.4 | 11/58 (19%) |
Others 13 | Plastic stent 19 | Partial liver infarction 1 | |||||||
No stent 4 | Hemobilia 3 | ||||||||
GB empyema 1 | |||||||||
Cholangitis 5 | |||||||||
Sepsis 2 | |||||||||
Hepatic coma 1 | |||||||||
LBBB 1 | |||||||||
Alis et al. [4] | 2013 | 17 | CCa (lesion unspecified) | 10 (58.8)b | Fully covered SEMS 10 | 270 | 3 | 3/10 (30%) | |
Pancreatitis: 2 | |||||||||
Strand et al. [11] | 2014 | 16 | CCa (hilar 13) | 10 (100) | Plastic stent 15 | 9.6 | 1.19 | ||
Fully covered SMES 5 | |||||||||
Uncovered SEMS 2 | |||||||||
Sharaiha et al. [9] | 2014 | 26 | CCa 18 | 26 (100) | Uncovered SEMS 7 | 5.9 | 5/26 (19.2%) | ||
Pancreatic cancer 8 | Covered SEMS 8 | Pancreatitis 1 | |||||||
Plastic stent 11 | Cholangitis 1 | ||||||||
Kallis et al. [18] | 2015 | 23 | Unresectable pancreatic cancer | 23 (100) | Uncovered SEMS 23 | 324 | 7.5 | 2/23 (8.7%) | |
Hyperamylasemia 1 | |||||||||
Cholangitis 1 | |||||||||
Sharaiha et al. [19] | 2015 | 69 | CCa 45 | 69 (100) | SEMS 49 | 11.5 | 1.4 | 7/69 (10.1%) | |
Pancreatic cancer 19 | Plastic stent 20 | PEP 1 | |||||||
GB cancer 2 | Cholecystitis 2 | ||||||||
Other 4 | Hemobilia 2 | ||||||||
Mild abdominal pain 3 | |||||||||
Laquiere et al. [8] | 2015 | 12 | 12 Cca (Hilar CCa. B‐I 4, B‐II 3, B‐III 2, B‐IV 3) | 12 (100) | SEMS or plastic stent | 12.3 | 1.63 (1‐3) | 2/12 (16.7%) | |
Sepsis: 1 | |||||||||
Cholangitis: 1 | |||||||||
Laleman et al. [7] | 2017 | 18 | Pancreatic cancer 7 | Distal: fully covered SEMS | 110 days | 7.6 | 1 | 6/18 (30%) | |
Distal CCa 2 | Hilar: plastic or uncovered SEMS | ‐ Distal 187 | Mild cholangitis 4 | ||||||
Hilar CCa 9 (Hilar CCa. B‐III 6, B‐IV 3) | ‐ Hilar 139 | Mild PEP 2c |
Values are presented as number (%).
RFA, radiofrequency ablation; CCa, cholangiocarcinoma; SEMS, self‐expandable metallic stent; LBBB, left bundle branch block; PEP: post‐ERCP pancreatitis.